Cargando…

COVID-19 Vaccination Status among Pregnant and Postpartum Women—A Cross-Sectional Study on More Than 1000 Individuals

Pregnancy is a well-known factor for vaccine hesitancy and immunization remains the most effective form of prevention against coronavirus disease (COVID-19) related complications. The objective was to estimate vaccine uptake and hesitancy rate, characteristics, and factors contributing to a decision...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowacka, Urszula, Malarkiewicz, Paulina, Sierdzinski, Janusz, Januszaniec, Aleksandra, Kozłowski, Szymon, Issat, Tadeusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330718/
https://www.ncbi.nlm.nih.gov/pubmed/35893827
http://dx.doi.org/10.3390/vaccines10081179
_version_ 1784758230482681856
author Nowacka, Urszula
Malarkiewicz, Paulina
Sierdzinski, Janusz
Januszaniec, Aleksandra
Kozłowski, Szymon
Issat, Tadeusz
author_facet Nowacka, Urszula
Malarkiewicz, Paulina
Sierdzinski, Janusz
Januszaniec, Aleksandra
Kozłowski, Szymon
Issat, Tadeusz
author_sort Nowacka, Urszula
collection PubMed
description Pregnancy is a well-known factor for vaccine hesitancy and immunization remains the most effective form of prevention against coronavirus disease (COVID-19) related complications. The objective was to estimate vaccine uptake and hesitancy rate, characteristics, and factors contributing to a decision-making process among pregnant and postpartum individuals. This was a prospective cross-sectional study on 1033 pregnant (54.1%) and postpartum (45.9%) women conducted between December 2021 and March 2022 in a tertiary center for maternal–fetal medicine. Logistic regression was used to assess characteristics related to the vaccination decision process. Among responders, 74% were vaccinated and 26% were hesitant (9% planning to vaccinate and 17% totally opposed). Only 59.8% were offered a vaccine by healthcare professionals. Women with higher levels of education (OR 2.26, p < 0.0001), who received positive feedback about vaccination (OR 2.74, p = 0.0172), or were informed about COVID-19 complications in pregnancy (OR 2.6, p < 0.0001) were most likely to accept the vaccination. Hesitancy was associated with multiparity (≥3, OR 4.76, p = 0.006), worse educational status (OR 2.29, p < 0.0001), and lack of previous COVID-19 infection (OR 1.89, p < 0.0001). The most common reason for rejection was insufficient safety data (57%). Understanding factors behind vaccination status is crucial in lowering complications in mothers and newborns and targeted action may facilitate the uptake.
format Online
Article
Text
id pubmed-9330718
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93307182022-07-29 COVID-19 Vaccination Status among Pregnant and Postpartum Women—A Cross-Sectional Study on More Than 1000 Individuals Nowacka, Urszula Malarkiewicz, Paulina Sierdzinski, Janusz Januszaniec, Aleksandra Kozłowski, Szymon Issat, Tadeusz Vaccines (Basel) Article Pregnancy is a well-known factor for vaccine hesitancy and immunization remains the most effective form of prevention against coronavirus disease (COVID-19) related complications. The objective was to estimate vaccine uptake and hesitancy rate, characteristics, and factors contributing to a decision-making process among pregnant and postpartum individuals. This was a prospective cross-sectional study on 1033 pregnant (54.1%) and postpartum (45.9%) women conducted between December 2021 and March 2022 in a tertiary center for maternal–fetal medicine. Logistic regression was used to assess characteristics related to the vaccination decision process. Among responders, 74% were vaccinated and 26% were hesitant (9% planning to vaccinate and 17% totally opposed). Only 59.8% were offered a vaccine by healthcare professionals. Women with higher levels of education (OR 2.26, p < 0.0001), who received positive feedback about vaccination (OR 2.74, p = 0.0172), or were informed about COVID-19 complications in pregnancy (OR 2.6, p < 0.0001) were most likely to accept the vaccination. Hesitancy was associated with multiparity (≥3, OR 4.76, p = 0.006), worse educational status (OR 2.29, p < 0.0001), and lack of previous COVID-19 infection (OR 1.89, p < 0.0001). The most common reason for rejection was insufficient safety data (57%). Understanding factors behind vaccination status is crucial in lowering complications in mothers and newborns and targeted action may facilitate the uptake. MDPI 2022-07-25 /pmc/articles/PMC9330718/ /pubmed/35893827 http://dx.doi.org/10.3390/vaccines10081179 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Nowacka, Urszula
Malarkiewicz, Paulina
Sierdzinski, Janusz
Januszaniec, Aleksandra
Kozłowski, Szymon
Issat, Tadeusz
COVID-19 Vaccination Status among Pregnant and Postpartum Women—A Cross-Sectional Study on More Than 1000 Individuals
title COVID-19 Vaccination Status among Pregnant and Postpartum Women—A Cross-Sectional Study on More Than 1000 Individuals
title_full COVID-19 Vaccination Status among Pregnant and Postpartum Women—A Cross-Sectional Study on More Than 1000 Individuals
title_fullStr COVID-19 Vaccination Status among Pregnant and Postpartum Women—A Cross-Sectional Study on More Than 1000 Individuals
title_full_unstemmed COVID-19 Vaccination Status among Pregnant and Postpartum Women—A Cross-Sectional Study on More Than 1000 Individuals
title_short COVID-19 Vaccination Status among Pregnant and Postpartum Women—A Cross-Sectional Study on More Than 1000 Individuals
title_sort covid-19 vaccination status among pregnant and postpartum women—a cross-sectional study on more than 1000 individuals
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330718/
https://www.ncbi.nlm.nih.gov/pubmed/35893827
http://dx.doi.org/10.3390/vaccines10081179
work_keys_str_mv AT nowackaurszula covid19vaccinationstatusamongpregnantandpostpartumwomenacrosssectionalstudyonmorethan1000individuals
AT malarkiewiczpaulina covid19vaccinationstatusamongpregnantandpostpartumwomenacrosssectionalstudyonmorethan1000individuals
AT sierdzinskijanusz covid19vaccinationstatusamongpregnantandpostpartumwomenacrosssectionalstudyonmorethan1000individuals
AT januszaniecaleksandra covid19vaccinationstatusamongpregnantandpostpartumwomenacrosssectionalstudyonmorethan1000individuals
AT kozłowskiszymon covid19vaccinationstatusamongpregnantandpostpartumwomenacrosssectionalstudyonmorethan1000individuals
AT issattadeusz covid19vaccinationstatusamongpregnantandpostpartumwomenacrosssectionalstudyonmorethan1000individuals